Kamil Rahme

Prof. Kamil Rahme

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2013 in RSC Advances
Verified
Journal Article
Closed access
PDF file
KRKamil Rahme
Kamil Rahme
Lan ChenLan Chen
Lan Chen
RHRichard G. Hobbs
Richard G. Hobbs
Michael A. MorrisMichael A. Morris
Michael A. Morris
COCaitriona M. O'Driscoll
Caitriona M. O'Driscoll
JHJustin D. Holmes
Justin D. Holmes
Au nanoparticles with diameters ranging between 15 and 170 nm have been synthesised in aqueous solution using a seed-mediated growth method, employing hydroxylamine hydrochloride as a reducing agent. Thiolated polyethylene glycol (mPEG-SH) polymers, with molecular weights ranging from 2100 to 51 000 g mol−1, were used as efficient particle stabilising ligands. Dynamic light scattering and zeta potential measurements confirmed that the overall mean diameter and zeta potential of the capped nanoparticles increased in a non-linear way with increasing molecular weight of the mPEG-SH ligand. Electron microscopy and thermal gravimetric analysis of the polymer-capped nanoparticles, with a mean gold core diameter of 15 nm, revealed that the grafting density of the mPEG-SH ligands decreased from 3.93 to 0.31 PEG nm−2 as the molecular weight of the ligands increased from 2100 to 51 400 g mol−1 respectively, due to increased steric hindrance and polymer conformational entropy with increase in the PEG chain length. Additionally, the number of bound mPEG-SH ligands, with a molecular weight of 10 800 g mol−1, was found to increase in a non-linear way from 278 (σ = 42) to approximately 12 960 PEG (σ = 1227) when the mean Au core diameter increased from 15 to 115 nm respectively. However, the grafting density of mPEG10 000-SH ligands was higher on 15 nm Au nanoparticles and decreased slightly from 1.57 to 0.8 PEG nm−2 when the diameter increased; this effect can be attributed to the fact that smaller particles offer higher surface curvature, therefore allowing increased polymer loading per nm2. Au nanoparticles were also shown to interact with CT-26 cells without causing noticeable toxicity.

1 July 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JGJianfeng Guo
Jianfeng Guo
COCaitriona M. O'Driscoll
Caitriona M. O'Driscoll
JHJustin D. Holmes
Justin D. Holmes
KRKamil Rahme
Kamil Rahme

11 July 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KRKamil Rahme
Kamil Rahme
NDNazih Dagher
Nazih Dagher
Polyethylene glycol (PEG) is one of the most frequently used polymers for coating nanocarriers to enhance their biocompatibility, hydrophilicity, stability, and biodegradability. PEG is now considered to be among the best biocompatible polymers. It offers sterical hindrance against other nanoparticles and blood components such as opsonin, preventing their macrophage phagocytosis and resulting in a prolonged circulation time in blood stream, consequently a ‘stealth character’ in vivo. Therefore, PEG has a very promising future for the development of current therapeutics and biomedical applications. Moreover, the vast number of molecules that PEG can conjugate with might enhance its ability to have an optimistic perspective for the future. This review will present an update on the chemistry used in the modern conjugation methods for a variety of PEG conjugates, such methods include, but are not limited to, the synthesis of targeting PEG conjugates (i.e., Peptides, Folate, Biotin, Mannose etc.), imaging PEG conjugates (i.e., Coumarin, Near Infrared dyes etc.) and delivery PEG conjugates (i.e., doxorubicin, paclitaxel, and other hydrophobic low molecular weight drugs). Furthermore, the type of nanoparticles carrying those conjugates, along with their biomedical uses, will be briefly discussed.

21 August 2013 in RSC Advances
Verified
Journal Article
Closed access
PDF file
KRKamil Rahme
Kamil Rahme
MNMarie Therese Nolan
Marie Therese Nolan
TDTimothy Doody
Timothy Doody
GMGerard P. McGlacken
Gerard P. McGlacken
Michael A. MorrisMichael A. Morris
Michael A. Morris
JHJustin D. Holmes
Justin D. Holmes
Here we report the synthesis of well dispersed gold nanoparticles (Au NPs), with diameters ranging between 5 and 60 nm, in water and demonstrate their potential usefulness in catalysis and biological applications. Functionalised polyethylene glycol-based thiol polymers (mPEG-SH) were used to stabilise the pre-synthesised NPs. Successful PEGylation of the NPs was confirmed by Dynamic Light Scattering (DLS) and zeta potential measurements. PEG coating of the NPs was found to be key to their colloidal stability in high ionic strength media, compared to bare citrate-stabilised NPs. Our results show that PEG–Au NPs with diameters <30 nm were useful as catalysts in the homocoupling of arylboronic acids in water. Additionally, PEG–Au NPs were also shown to be stable in biological fluids, non-cytotoxic to B16.F10 and CT-26 cell lines and able to successfully deliver siRNA to CT-26 cells, achieving a significant reduction (p < 0.05) in the expression levels of luciferase protein; making these NPs attractive for further biological studies.

8 March 2016 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
KFKathleen A. Fitzgerald
Kathleen A. Fitzgerald
KRKamil Rahme
Kamil Rahme
JGJianfeng Guo
Jianfeng Guo
JHJustin D. Holmes
Justin D. Holmes
COCaitriona M. O'Driscoll
Caitriona M. O'Driscoll
Metastatic prostate cancer is a leading cause of cancer-related death in men and current chemotherapies are largely inadequate in terms of efficacy and toxicity. Hence improved treatments are required. The application of siRNA as a cancer therapeutic holds great promise. However, translation of siRNA into the clinic is dependent on the availability of an effective delivery system. Gold nanoparticles (AuNPs) are known to be effective and non-toxic siRNA delivery agents. In this study, a stable gold nanosphere coated with poly(ethylenimine) (PEI) was prepared to yield PEI capped AuNPs (Au-PEI). The PEI was further conjugated with the targeting ligand anisamide (AA, is known to bind to the sigma receptor overexpressed on the surface of prostate cancer cells) to produce an anisamide-targeted nanoparticle (Au-PEI-AA). The resulting untargeted and targeted nanoparticles (Au-PEI and Au-PEI-AA respectively) were positively charged and efficiently complexed siRNA. Au-PEI-AA mediated siRNA uptake into PC3 prostate cancer cells via binding to the sigma receptor. In addition, the Au-PEI-AA·siRNA complexes resulted in highly efficient knockdown of the RelA gene (∼70%) when cells were transfected in serum-free medium. In contrast, no knockdown was observed in the presence of serum, suggesting that adsorption of serum proteins inhibits the binding of the anisamide moiety to the sigma receptor. This study provides (for the first time) proof of principle that anisamide-labelled gold nanoparticles can target the sigma receptor. Further optimisation of the formulation to increase serum stability will enhance its potential to treat prostate cancer.

3 February 2015 in RSC Advances
Verified
Journal Article
Open access
PDF file
JGJianfeng Guo
Jianfeng Guo
MAMark J. Armstrong
Mark J. Armstrong
COCaitriona M. O'Driscoll
Caitriona M. O'Driscoll
JHJustin D. Holmes
Justin D. Holmes
KRKamil Rahme
Kamil Rahme
Positively charged, surfactant–free gold nanoparticles (Au NPs) with diameters ranging between 2–200 nm have been synthesised in water via a seed-mediated growth method, involving the reduction of gold(III) chloride (AuCl3) by hydroxylamine hydrochloride (NH2OH·HCl) in the presence of L-cysteine methyl ester hydrochloride (HSCH2CH(NH2)COOCH3·HCl) as a capping agent. The mercapto group (–SH) on the capping ligand has a high affinity for Au, anchoring the cysteine group to the nanoparticles, whilst the ammonium group (–NH3 +), formed by the presence of an amine group in slightly acidic media (pH ∼ 4.5–5), resulted in positively charged colloidal nanoparticles (ζ-potential +33 to +49 mV), which was key to their electrostatic stability. Data from cytotoxicity studies performed on a range of different cell types (human and murine), including human prostate cancer cells (PC3), showed that the positively charged Au–L-cysteine–cysteine nanoparticles were less cytotoxic than positively charged Au NPs produced using commonly employed surfactant cetyl trimethyl ammonium bromide (CTAB) under similar conditions. In addition, the positively charged Au NPs could be successfully complexed with small interfering RNA (siRNA). At the cellular level, the uptake of fluorescein siRNA from the charged nanoparticles was comparable to uptake from the commercial carrier INTERFRin™, implying the potential application of these novel vectors for nucleic acid delivery.